UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Hypertension (Dallas, Tex. 1979), 2020-06, Vol.75 (6), p.1334-1357

2020

Volltextzugriff (PDF)

AT2 receptors in cardiovascular and renal diseases

Pharmacological research, 2017-11, Vol.125 (Pt A), p.39-47

2017

Volltextzugriff (PDF)

The (Pro)renin Receptor - A Regulatory Nodal Point in Disease Networks

Current drug targets, 2023-01, Vol.24 (14), p.1093-1098

2023

Volltextzugriff (PDF)

The role of the renin-angiotensin system in the development of cardiovascular disease

The American journal of cardiology, 2002-01, Vol.89 (2), p.3-9

Unger, Thomas

2002

Volltextzugriff (PDF)

Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison

Clinical science (1979), 2015-02, Vol.128 (4), p.227-234

2015

Volltextzugriff (PDF)

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

Drugs (New York, N.Y.), 2016-01, Vol.76 (1), p.1-12

2016

Volltextzugriff (PDF)

The endothelium and vascular inflammation in diabetes

Diabetes & vascular disease research, 2007-06, Vol.4 (2), p.84-88

2007

Volltextzugriff (PDF)

Protective arms of the renin-angiotensin-system in neurological disease

Clinical and experimental pharmacology & physiology, 2013-08, Vol.40 (8), p.580-588

2013

Volltextzugriff (PDF)

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

Lancet neurology, 2011, Vol.10 (1), p.43-53

2011

Volltextzugriff (PDF)

Antihypertensive prescription patterns and cardiovascular risk in patients with newly diagnosed hypertension- an analysis of statutory health insurance data in Germany

Blood pressure, 2020-11, Vol.29 (6), p.357-361

2020

Volltextzugriff (PDF)

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

The New England journal of medicine, 2005-02, Vol.352 (6), p.558-569

2005

Volltextzugriff (PDF)

Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

British journal of pharmacology, 2016-02, Vol.173 (4), p.729-740

2016

Volltextzugriff (PDF)

Response to the editorial: "the international society of hypertension guidelines 2020 - a new drug treatment recommendation in the wrong direction?"

Blood pressure, 2020-11, Vol.29 (6), p.339-340

2020

Volltextzugriff (PDF)

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

Journal of the renin-angiotensin-aldosterone system, 2010-03, Vol.11 (1), p.75-77

2010

Volltextzugriff (PDF)

Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease

The American heart journal, 2013-08, Vol.166 (2), p.306-314.e7

2013

Volltextzugriff (PDF)

The evolving story of the RAAS in hypertension, diabetes and CV disease - moving from macrovascular to microvascular targets

Fundamental & clinical pharmacology, 2009-12, Vol.23 (6), p.693-703

2009

Volltextzugriff (PDF)

Rationale for Double Renin-Angiotensin-Aldosterone System Blockade

The American journal of cardiology, 2007-08, Vol.100 (3), p.S25-S31

2007

Volltextzugriff (PDF)

Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension

BMJ open, 2021-02, Vol.11 (2), p.e043625-e043625

2021

Volltextzugriff (PDF)

Plasma Renin and Cardiovascular Risk: What Is the Evidence for an Association?

Cardiology, 2013-01, Vol.125 (1), p.50-59

2013

Volltextzugriff (PDF)

AT2 Receptors Targeting Cardiac Protection Post-Myocardial Infarction

Current hypertension reports, 2014-07, Vol.16 (7), p.441-441, Article 441

2014

Volltextzugriff (PDF)

Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren

Journal of hypertension, 2008-09, Vol.26 (9), p.1787-1794

2008

Volltextzugriff (PDF)

Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage

Hypertension research, 2010-02, Vol.33 (2), p.98-104

2010

Volltextzugriff (PDF)

The past, present and future of angiotensin II type 2 receptor stimulation

Journal of the renin-angiotensin-aldosterone system, 2010-03, Vol.11 (1), p.67-73

2010

Volltextzugriff (PDF)

Angiotensin II and the fibroproliferative response to acute lung injury

American journal of physiology. Lung cellular and molecular physiology, 2004-01, Vol.286 (1), p.156-L164

2004

Volltextzugriff (PDF)

Novel therapeutic targets for hypertension

Nature reviews cardiology, 2010-08, Vol.7 (8), p.431-441

2010

Volltextzugriff (PDF)

1 – 25 von 478

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(457)
Mit Volltextzugriff
(393)

Publikationsform

Artikel
(477)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

2020 International Society of Hypertension Global Hypertension Practice Guidelines

AT2 receptors in cardiovascular and renal diseases

The (Pro)renin Receptor - A Regulatory Nodal Point in Disease Networks

The role of the renin-angiotensin system in the development of cardiovascular disease

Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

The endothelium and vascular inflammation in diabetes

Protective arms of the renin-angiotensin-system in neurological disease

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

Antihypertensive prescription patterns and cardiovascular risk in patients with newly diagnosed hypertension- an analysis of statutory health insurance data in Germany

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

Response to the editorial: "the international society of hypertension guidelines 2020 - a new drug treatment recommendation in the wrong direction?"

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease

The evolving story of the RAAS in hypertension, diabetes and CV disease - moving from macrovascular to microvascular targets

Rationale for Double Renin-Angiotensin-Aldosterone System Blockade

Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension

Plasma Renin and Cardiovascular Risk: What Is the Evidence for an Association?

AT2 Receptors Targeting Cardiac Protection Post-Myocardial Infarction

Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren

Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage

The past, present and future of angiotensin II type 2 receptor stimulation

Angiotensin II and the fibroproliferative response to acute lung injury

Novel therapeutic targets for hypertension

Aktive Filter

Suchergebnisse filtern